Evolent Health (EVH) Receivables - Other (2015 - 2021)

Evolent Health has reported Receivables - Other for 7 years, with the latest figure at $190000.0 in Q1 2021.

• For the quarter ending Q1 2021, Receivables - Other fell 89.16% year-over-year to $190000.0; the trailing twelve-month figure through Mar 2021 stood at $190000.0 (down 89.16% YoY), and the FY2020 full-year result was $329000.0, down 81.21% from the prior year.
• Receivables - Other for Q1 2021 stood at $190000.0, down from $329000.0 in the prior quarter.
• The five-year high for Receivables - Other was $10.1 million in Q3 2019, with the low at $190000.0 in Q1 2021.
• Average Receivables - Other over 5 years is $3.7 million, with a median of $2.1 million recorded in 2018.
• Peak annual rise in Receivables - Other reached 36.66% in 2020, while the deepest fall reached 93.33% in 2020.
• Tracing EVH's Receivables - Other over 5 years: stood at $5.7 million in 2017, then tumbled by 63.38% to $2.1 million in 2018, then fell by 16.7% to $1.8 million in 2019, then tumbled by 81.21% to $329000.0 in 2020, then slumped by 42.25% to $190000.0 in 2021.
• The last three Receivables - Other figures came in at $190000.0 (Q1 2021), $329000.0 (Q4 2020), and $671000.0 (Q3 2020), per Business Quant data.

Peer Comparison